The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Global Epidemiology and Genetics of Hepatocellular Carcinoma
Open accessAbstract
Hepatocellular carcinoma (HCC) is one of the leading cancers worldwide. Classically, HCC develops in genetically susceptible individuals who are exposed to risk factors, especially in the presence of liver cirrhosis. Significant temporal and geographic variations exist for HCC and its etiologies. Over time, the burden of HCC has shifted from the low-moderate to the high sociodemographic index regions, reflecting the transition from viral to nonviral causes. Geographically, the hepatitis viruses predominate as the causes of HCC in Asia and Africa. Although there are genetic conditions that confer increased risk for HCC, these diagnoses are rarely recognized outside North America and Europe. In this review, we will evaluate the epidemiologic trends and risk factors of HCC, and discuss the genetics of HCC, including monogenic diseases, single-nucleotide polymorphisms, gut microbiome, and somatic mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492
Estes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Omata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
Epidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & El‐Serag, H. B. (2021) · Hepatology · doi:10.1002/hep.31288 · Cited by 2,147
Global Burden of Disease Liver Cancer Collaboration, Akinyemiju, T., Abera, S., Ahmed, M., Alam, N., Alemayohu, M. A., Allen, C., Al-Raddadi, R., Alvis-Guzman, N., Amoako, Y., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3055 · Cited by 1,987
Estes, C., Anstee, Q. M., Arias-Loste, M. T., Bantel, H., Bellentani, S., Caballeria, J., Colombo, M., Craxi, A., Crespo, J., Day, C. P., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.036 · Cited by 1,980
Cunningham, F., Allen, J. E., Allen, J., Alvarez-Jarreta, J., Amode, M. R., Armean, I. M., Austine-Orimoloye, O., Azov, A. G., Barnes, I., Bennett, R., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1049 · Cited by 1,923
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00381-6 · Cited by 1,855
Schulze, K., Imbeaud, S., Letouzé, E., Alexandrov, L. B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3252 · Cited by 1,803
Deep profiling of mouse splenic architecture with CODEX multiplexed imaging
Goltsev, Y., Samusik, N., Kennedy-Darling, J., Bhate, S., Hale, M., Vazquez, G., Black, S., & Nolan, G. P. (2018) · Cell · doi:10.1016/j.cell.2018.07.010 · Cited by 1,501
Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis
Bagnardi, V, Rota, M., Botteri, E., Tramacere, I., Islami, F., Fedirko, V, Scotti, L., Jenab, M., Turati, F., Pasquali, E., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.579 · Cited by 1,342
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330
Genetic landscape and biomarkers of hepatocellular carcinoma
Zucman-Rossi, J., Villanueva, A., Nault, J.-C., & Llovet, J. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.061 · Cited by 1,325
Hepatocellular carcinoma: a global view
Yang, J. D., & Roberts, L. R. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.100 · Cited by 1,286
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Younossi, Z. M., Blissett, D., Blissett, R., Henry, L., Stepanova, M., Younossi, Y., Racila, A., Hunt, S., & Beckerman, R. (2016) · Hepatology · doi:10.1002/hep.28785 · Cited by 1,285
Global burden of aflatoxin-induced hepatocellular carcinoma: A risk assessment
Liu, Y., & Wu, F. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901388 · Cited by 1,224
Epidemiology and natural history of HCV infection
Hajarizadeh, B., Grebely, J., & Dore, G. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.107 · Cited by 994
Gut microbiota modulation of chemotherapy efficacy and toxicity
Alexander, J. L., Wilson, I. D., Teare, J., Marchesi, J. R., Nicholson, J. K., & Kinross, J. M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.20 · Cited by 970
Prevalence and Treatment of Diabetes in China, 2013-2018
Wang, L., Peng, W., Zhao, Z., Zhang, M., Shi, Z., Song, Z., Zhang, X., Li, C., Huang, Z., Sun, X., et al. (2021) · JAMA · doi:10.1001/jama.2021.22208 · Cited by 961
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Kanwal, F., Kramer, J., Asch, S. M., Chayanupatkul, M., Cao, Y., & El-Serag, H. B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.012 · Cited by 931
Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study
Manthey, J., Shield, K. D., Rylett, M., Hasan, O. S. M., Probst, C., & Rehm, J. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32744-2 · Cited by 856
Sheena, B. S., Hiebert, L., Han, H., Ippolito, H., Abbasi-Kangevari, M., Abbasi-Kangevari, Z., Abbastabar, H., Abdoli, A., Abubaker Ali, H., Adane, M. M., et al. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(22)00124-8 · Cited by 805
Younossi, Z. M., Otgonsuren, M., Henry, L., Venkatesan, C., Mishra, A., Erario, M., & Hunt, S. (2015) · Hepatology · doi:10.1002/hep.28123 · Cited by 802
Hassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology · doi:10.1053/jhep.2002.36780 · Cited by 762
Hosaka, T., Suzuki, F., Kobayashi, M., Seko, Y., Kawamura, Y., Sezaki, H., Akuta, N., Suzuki, Y., Saitoh, S., Arase, Y., et al. (2013) · Hepatology · doi:10.1002/hep.26180 · Cited by 710
Pimpin, L., Cortez-Pinto, H., Negro, F., Corbould, E., Lazarus, J. V., Webber, L., & Sheron, N. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.011 · Cited by 710
Epidemiological Features of NAFLD From 1999 to 2018 in China
Zhou, J., Zhou, F., Wang, W., Zhang, X., Ji, Y., Zhang, P., She, Z., Zhu, L., Cai, J., & Li, H. (2020) · Hepatology · doi:10.1002/hep.31150 · Cited by 678
Pan-cancer integrative histology-genomic analysis via multimodal deep learning
Chen, R. J., Lu, M. Y., Williamson, D. F. K., Chen, T. Y., Lipkova, J., Noor, Z., Shaban, M., Shady, M., Williams, M., Joo, B., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.07.004 · Cited by 660
Ponziani, F. R., Bhoori, S., Castelli, C., Putignani, L., Rivoltini, L., Del Chierico, F., Sanguinetti, M., Morelli, D., Paroni Sterbini, F., Petito, V., et al. (2019) · Hepatology · doi:10.1002/hep.30036 · Cited by 654
Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01701-3 · Cited by 652
Blach, S., Terrault, N. A., Tacke, F., Gamkrelidze, I., Craxi, A., Tanaka, J., Waked, I., Dore, G. J., Abbas, Z., Abdallah, A. R., et al. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00472-6 · Cited by 641
Alcohol and hepatocellular carcinoma
Morgan, T. R., Mandayam, S., & Jamal, M. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.020 · Cited by 625
Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study
Merle, U., Schaefer, M., Ferenci, P., & Stremmel, W. (2007) · Gut · doi:10.1136/gut.2005.087262 · Cited by 625
Liu, Y.-L., Reeves, H. L., Burt, A. D., Tiniakos, D., McPherson, S., Leathart, J. B. S., Allison, M. E. D., Alexander, G. J., Piguet, A.-C., Anty, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5309 · Cited by 623
Spatial omics and multiplexed imaging to explore cancer biology
Lewis, S. M., Asselin-Labat, M.-L., Nguyen, Q., Berthelet, J., Tan, X., Wimmer, V. C., Merino, D., Rogers, K. L., & Naik, S. H. (2021) · Nature Methods · doi:10.1038/s41592-021-01203-6 · Cited by 619
Bryazka, D., Reitsma, M. B., Griswold, M. G., Abate, K. H., Abbafati, C., Abbasi-Kangevari, M., Abbasi-Kangevari, Z., Abdoli, A., Abdollahi, M., Abdullah, A. Y. M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00847-9 · Cited by 582
Younossi, Z. M., Stepanova, M., Ong, J., Trimble, G., AlQahtani, S., Younossi, I., Ahmed, A., Racila, A., & Henry, L. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.05.064 · Cited by 576
Hughes, S. A., Wedemeyer, H., & Harrison, P. M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61931-9 · Cited by 570
Buch, S., Stickel, F., Trépo, E., Way, M., Herrmann, A., Nischalke, H. D., Brosch, M., Rosendahl, J., Berg, T., Ridinger, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3417 · Cited by 565
The Etiology of Hepatocellular Carcinoma and Consequences for Treatment
Sanyal, A. J., Yoon, S. K., & Lencioni, R. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s4-14 · Cited by 517
US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2018) · JAMA · doi:10.1001/jama.2018.16789 · Cited by 509
Adam, R., Karam, V., Cailliez, V., O Grady, J. G., Mirza, D., Cherqui, D., Klempnauer, J., Salizzoni, M., Pratschke, J., Jamieson, N., et al. (2018) · Transplant International · doi:10.1111/tri.13358 · Cited by 498
Wong, G. L.-H., Chan, H. L.-Y., Mak, C. W.-H., Lee, S. K.-Y., Ip, Z. M.-Y., Lam, A. T.-H., Iu, H. W.-H., Leung, J. M.-S., Lai, J. W.-Y., Lo, A. O.-S., et al. (2013) · Hepatology · doi:10.1002/hep.26301 · Cited by 488
Loo, T. M., Kamachi, F., Watanabe, Y., Yoshimoto, S., Kanda, H., Arai, Y., Nakajima-Takagi, Y., Iwama, A., Koga, T., Sugimoto, Y., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0932 · Cited by 478
Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction
Kanwal, F., & Singal, A. G. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.02.049 · Cited by 471
Behary, J., Amorim, N., Jiang, X.-T., Raposo, A., Gong, L., McGovern, E., Ibrahim, R., Chu, F., Stephens, C., Jebeili, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20422-7 · Cited by 470
Singal, A. G., Zhang, E., Narasimman, M., Rich, N. E., Waljee, A. K., Hoshida, Y., Yang, J. D., Reig, M., Cabibbo, G., Nahon, P., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.01.023 · Cited by 451
Hwang, W. L., Jagadeesh, K. A., Guo, J. A., Hoffman, H. I., Yadollahpour, P., Reeves, J. W., Mohan, R., Drokhlyansky, E., Van Wittenberghe, N., Ashenberg, O., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01134-8 · Cited by 426
Bianco, C., Jamialahmadi, O., Pelusi, S., Baselli, G., Dongiovanni, P., Zanoni, I., Santoro, L., Maier, S., Liguori, A., Meroni, M., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.024 · Cited by 385
Ng, A. W. T., Poon, S. L., Huang, M. N., Lim, J. Q., Boot, A., Yu, W., Suzuki, Y., Thangaraju, S., Ng, C. C. Y., Tan, P., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan6446 · Cited by 381
Self-citationMeta‐analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
SUNG, J. J. Y., TSOI, K. K. F., WONG, V. W. S., LI, K. C. T., & CHAN, H. L. Y. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03816.x · Cited by 370
Gut microbiome in HCC – Mechanisms, diagnosis and therapy
Schwabe, R. F., & Greten, T. F. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.016 · Cited by 363
Intratumoral heterogeneity and clonal evolution in liver cancer
Losic, B., Craig, A. J., Villacorta-Martin, C., Martins-Filho, S. N., Akers, N., Chen, X., Ahsen, M. E., von Felden, J., Labgaa, I., DʹAvola, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14050-z · Cited by 363
Singal, A. G., Manjunath, H., Yopp, A. C., Beg, M. S., Marrero, J. A., Gopal, P., & Waljee, A. K. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.476 · Cited by 362
Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets
Spearman, C. W., Afihene, M., Ally, R., Apica, B., Awuku, Y., Cunha, L., Dusheiko, G., Gogela, N., Kassianides, C., Kew, M., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30295-9 · Cited by 361
Hepatocellular carcinoma in the setting of alcohol-related liver disease
Ganne-Carrié, N., & Nahon, P. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.008 · Cited by 360
Loomba, R., Lim, J. K., Patton, H., & El-Serag, H. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.053 · Cited by 357
Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
Nair, S., Mason, A., Eason, J., Loss, G., & Perrillo, R. P. (2002) · Hepatology · doi:10.1053/jhep.2002.33713 · Cited by 348
Image-based multivariate profiling of drug responses from single cells
Loo, L.-H., Wu, L. F., & Altschuler, S. J. (2007) · Nature Methods · doi:10.1038/nmeth1032 · Cited by 343
Self-citationLiver cancer incidence and mortality in China: Temporal trends and projections to 2030
Zheng, R., Office for Cancer Registry, N. C. C. C. R. C. F. C. H., Qu, C., Zhang, S., Zeng, H., Sun, K., Gu, X., Xia, C., Yang, Z., Li, H., et al. (2018) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2018.06.01 · Cited by 343
Wu, C.-Y., Lin, J.-T., Ho, H. J., Su, C.-W., Lee, T.-Y., Wang, S.-Y., Wu, C., & Wu, J.-C. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.048 · Cited by 319
Genetic profiling of hepatocellular carcinoma using next-generation sequencing
Schulze, K., Nault, J.-C., & Villanueva, A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.035 · Cited by 317
Haldar, D., Kern, B., Hodson, J., Armstrong, M. J., Adam, R., Berlakovich, G., Fritz, J., Feurstein, B., Popp, W., Karam, V., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.011 · Cited by 313
Tan, D. J. H., Ng, C. H., Lin, S. Y., Pan, X. H., Tay, P., Lim, W. H., Teng, M., Syn, N., Lim, G., Yong, J. N., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00078-x · Cited by 307
Heterogeneity of the tumor immune microenvironment and its clinical relevance
Jia, Q., Wang, A., Yuan, Y., Zhu, B., & Long, H. (2022) · Experimental Hematology & Oncology · doi:10.1186/s40164-022-00277-y · Cited by 300
Yang, J. D., Mohamed, E. A., Aziz, A. O. A., Shousha, H. I., Hashem, M. B., Nabeel, M. M., Abdelmaksoud, A. H., Elbaz, T. M., Afihene, M. Y., Duduyemi, B. M., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30161-3 · Cited by 278
Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives
Elmberg, M., Hultcrantz, R., Ekbom, A., Brandt, L., Olsson, S., Olsson, R., Lindgren, S., Lööf, L., Stål, P., Wallerstedt, S., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.035 · Cited by 273
ACG Clinical Guideline: Hereditary Hemochromatosis
Kowdley, K. V., Brown, K. E., Ahn, J., & Sundaram, V. (2019) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000315 · Cited by 272
The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations
Safreed-Harmon, K., Thursz, M., Dillon, J., El-Sayed, M., Elsharkawy, A., Hatzakis, A., Jadoul, M., Prestileo, T., Razavi, H., Rockstroh, J., et al. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1666841 · Cited by 257
Gender Disparity of Hepatocellular Carcinoma: The Roles of Sex Hormones
Yeh, S.-H., & Chen, P.-J. (2010) · Oncology · doi:10.1159/000315247 · Cited by 256
Thirty-Year Outcomes of the National Hepatitis B Immunization Program in Taiwan
Chiang, C.-J., Yang, Y.-W., You, S.-L., Lai, M.-S., & Chen, C.-J. (2013) · JAMA · doi:10.1001/jama.2013.276701 · Cited by 247
Micro-elimination – A path to global elimination of hepatitis C
Lazarus, J. V., Wiktor, S., Colombo, M., & Thursz, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.033 · Cited by 234
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
Tateishi, R., Uchino, K., Fujiwara, N., Takehara, T., Okanoue, T., Seike, M., Yoshiji, H., Yatsuhashi, H., Shimizu, M., Torimura, T., et al. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-018-1532-5 · Cited by 231
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies
Turati, F., Galeone, C., Rota, M., Pelucchi, C., Negri, E., Bagnardi, V., Corrao, G., Boffetta, P., & La Vecchia, C. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu020 · Cited by 229
Yang, J. D., Ahmed, F., Mara, K. C., Addissie, B. D., Allen, A. M., Gores, G. J., & Roberts, L. R. (2020) · Hepatology · doi:10.1002/hep.30858 · Cited by 209
Grąt, M., Wronka, K. M., Krasnodębski, M., Masior, Ł., Lewandowski, Z., Kosińska, I., Grąt, K., Stypułkowski, J., Rejowski, S., Wasilewicz, M., et al. (2016) · Transplantation Proceedings · doi:10.1016/j.transproceed.2016.01.077 · Cited by 206
Tarao, K., Nozaki, A., Ikeda, T., Sato, A., Komatsu, H., Komatsu, T., Taguri, M., & Tanaka, K. (2019) · Cancer Medicine · doi:10.1002/cam4.1998 · Cited by 205
Platt, L., French, C. E., McGowan, C. R., Sabin, K., Gower, E., Trickey, A., McDonald, B., Ong, J., Stone, J., Easterbrook, P., et al. (2020) · Journal of Viral Hepatitis · doi:10.1111/jvh.13217 · Cited by 203
Hepatocellular Carcinoma Survival by Etiology: A SEER‐Medicare Database Analysis
Brar, G., Greten, T. F., Graubard, B. I., McNeel, T. S., Petrick, J. L., McGlynn, K. A., & Altekruse, S. F. (2020) · Hepatology Communications · doi:10.1002/hep4.1564 · Cited by 178
Is it possible to halve the incidence of liver cancer in China by 2050?
Shi, J., Cao, M., Wang, Y., Bai, F., Lei, L., Peng, J., Feletto, E., Canfell, K., Qu, C., & Chen, W. (2021) · International Journal of Cancer · doi:10.1002/ijc.33313 · Cited by 177
Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis
Nahon, P., & Zucman-Rossi, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.035 · Cited by 176
Clinical guide and update on porphyrias
Stölzel, U., Doss, M. O., & Schuppan, D. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.050 · Cited by 175
Dietary iron overload as a risk factor for hepatocellular carcinoma in black africans
Mandishona, E., MacPhail, P. A., Gordeuk, V. R., Kedda, M.-A., Paterson, A. C., Rouault, T. A., & Kew, M. C. (1998) · Hepatology · doi:10.1002/hep.510270614 · Cited by 170
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
Lazarus, J. V., Ekstedt, M., Marchesini, G., Mullen, J., Novak, K., Pericàs, J. M., Roel, E., Romero-Gómez, M., Ratziu, V., Tacke, F., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.027 · Cited by 167
Ageing as an Important Risk Factor for Cancer
Smetana, K., Lacina, L., Szabó, P., Dvořánková, B., Brož, P., & Šedo, A. (2016) · Anticancer Research · doi:10.21873/anticanres.11069 · Cited by 165
Rajoriya, N., Combet, C., Zoulim, F., & Janssen, H. L. A. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.011 · Cited by 163
Han, J., Xian, Z., Zhang, Y., Liu, J., & Liang, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00648 · Cited by 162
Keane, E., Funk, A. L., & Shimakawa, Y. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13795 · Cited by 161
Time trends of chronic HBV infection over prior decades – A global analysis
Ott, J. J., Horn, J., Krause, G., & Mikolajczyk, R. T. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.013 · Cited by 160
Ito, T., Ishigami, M., Zou, B., Tanaka, T., Takahashi, H., Kurosaki, M., Maeda, M., Thin, K. N., Tanaka, K., Takahashi, Y., et al. (2021) · Hepatology International · doi:10.1007/s12072-021-10143-4 · Cited by 160
The gut microbiome: what the oncologist ought to know
Lee, K. A., Luong, M., Shaw, H. M., Nathan, P., Bataille, V. A., & Spector, T. D. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01467-x · Cited by 159
Nguyen, P. H. D., Ma, S., Phua, C. Z. J., Kaya, N. A., Lai, H. L. H., Lim, C. J., Lim, J. Q., Wasser, M., Lai, L., Tam, W. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20171-7 · Cited by 156
Self-citationEpidemiology of hepatitis C virus infection
Roudot‐Thoraval, F. (2021) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2020.101596 · Cited by 156
NAFLD — sounding the alarm on a silent epidemic
Lazarus, J. V., Colombo, M. G., Cortez‐Pinto, H., Huang, T. T. ‐., Miller, V., Ninburg, M. H., Schattenberg, J. M., Seim, L., Wong, V. W., & Zelber‐Sagi, S. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0315-7 · Cited by 149
HFE-associated hereditary hemochromatosis
Alexander, J., & Kowdley, K. V. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e31819d30f2 · Cited by 141
Liquid biopsy in the clinical management of hepatocellular carcinoma
von Felden, J., Garcia-Lezana, T., Schulze, K., Losic, B., & Villanueva, A. (2020) · Gut · doi:10.1136/gutjnl-2019-320282 · Cited by 141
Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database
Ding, J., & Wen, Z. (2021) · BMC Cancer · doi:10.1186/s12885-021-08904-3 · Cited by 136
Epidemiology of hepatocellular carcinoma in sub-Saharan Africa
Kew, M. C. (2013) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31354-7 · Cited by 132
Yamada, S., Takashina, Y., 渡辺, 光., Nagamine, R., Saito, Y., Kamada, N., & Saito, H. (2018) · Oncotarget · doi:10.18632/oncotarget.24066 · Cited by 132
Ni, J., Huang, R., Zhou, H., Xu, X., Li, Y., Cao, P., Zhong, K., Ge, M., Chen, X., Hou, B., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01458 · Cited by 123
The genomic landscape of Mongolian hepatocellular carcinoma
Candia, J., Bayarsaikhan, E., Tandon, M., Budhu, A., Forgues, M., Товуу, Л.-О., Tudev, U., Lack, J., Chao, A., Chinburen, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18186-1 · Cited by 123
Goutté, N., Sogni, P., Bendersky, N., Barbare, J., Falissard, B., & Farges, O. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.10.015 · Cited by 121
Kuper, H., Ye, W., Broomé, U., ROMELSJÖ, A., Mucci, L. A., Ekbom, A., Adami, H., Trichopoulos, D., & Nyrén, O. (2001) · Hepatology · doi:10.1053/jhep.2001.28233 · Cited by 119
Crownover, B. K., & Covey, C. J. (2013) · PubMed · Cited by 117
Hepatocellular Carcinoma in Sub-Saharan Africa
Mukthinuthalapati, V. V. P. K., Sewram, V., Ndlovu, N., Kimani, S., Abdelaziz, A. O., Chiao, E. Y., & Abou-Alfa, G. K. (2021) · JCO Global Oncology · doi:10.1200/go.20.00425 · Cited by 115
Prevention of vertical transmission of hepatitis B virus infection
Veronese, P., Dodi, I., Esposito, S., & Indolfi, G. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i26.4182 · Cited by 114
The global prevalence of Wilson disease from next-generation sequencing data
Gao, J., Brackley, S., & Mann, J. P. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0309-9 · Cited by 113
Trépo, E., Caruso, S., Yang, J., Imbeaud, S., Couchy, G., Bayard, Q., Letouzé, É., Ganne‐Carrié, N., Moreno, C., Oussalah, A., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00603-3 · Cited by 112
Current status of liver transplantation in Europe
Müller, P. C., Kabaçam, G., Vibert, É., Germani, G., & Petrowsky, H. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.05.062 · Cited by 109
The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma
Flores, J. E., Thompson, A. J. V., Ryan, M. C., & Howell, J. A. (2022) · Vaccines · doi:10.3390/vaccines10050793 · Cited by 109
Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity
Caruso, S., O’Brien, D. R., Cleary, S. P., Roberts, L. R., & Zucman‐Rossi, J. (2020) · Hepatology · doi:10.1002/hep.31394 · Cited by 103
Yang, J., Pan, G., Guan, L., Liu, Z., Wu, Y., Liu, Z., Lu, W., Li, S., Xu, H., & Ouyang, G. (2022) · Cancer Medicine · doi:10.1002/cam4.4530 · Cited by 100
Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
Debes, J. D., Chan, A. J., Balderramo, D. C., Kikuchi, L., Ballerga, E. G., Prieto, J. E., Tapias, M., Víctor Idrovo, C., Davalos, M. B., Cairo, F. M., et al. (2017) · Liver International · doi:10.1111/liv.13502 · Cited by 96
Chrysavgis, L., Giannakodimos, I., Diamantopoulou, P., & Cholongitas, Ε. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i3.310 · Cited by 93
The Microbiota and Cancer Cachexia
Herremans, K. M., Riner, A. N., Cameron, M. E., & Trevino, J. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246267 · Cited by 91
Global Disparities in Hepatitis B Elimination—A Focus on Africa
Sonderup, M. W., & Spearman, C. W. (2022) · Viruses · doi:10.3390/v14010082 · Cited by 89
Costentin, C. E., Mourad, A., Lahmek, P., Causse, X., Pariente, A. E., Hagège, H., Dobrin, A.-S., Becker, C., Marks, B., Bader, R., et al. (2018) · Cancer · doi:10.1002/cncr.31215 · Cited by 85
Paik, J. M., Golabi, P., Biswas, R., Alqahtani, S. A., Venkatesan, C., & Younossi, Z. M. (2020) · Hepatology Communications · doi:10.1002/hep4.1510 · Cited by 85
Zhai, W., Lai, H. L. H., Kaya, N. A., Chen, J., Yang, H., Lu, B., Lim, J. Q., Ma, S., Chew, S. C., Chua, K. P., et al. (2021) · National Science Review · doi:10.1093/nsr/nwab192 · Cited by 84
Self-citationLiver disease in adults with severe alpha-1-antitrypsin deficiency
Tanash, H. A., & Piitulainen, E. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-019-01548-y · Cited by 81
Large‐scale image‐based screening and profiling of cellular phenotypes
Bougen-Zhukov, N. M., Loh, S. Y. M., Lee, H. K., & Loo, L. (2016) · Cytometry Part A · doi:10.1002/cyto.a.22909 · Cited by 79
Self-citationAustralian recommendations for the management of hepatocellular carcinoma: a consensus statement
Lubel, J. S., Roberts, S. K., Strasser, S. I., Thompson, A. J. V., Philip, J. A. M., Goodwin, M. D., Clarke, S. J., Crawford, D. H., Levy, M. T., & Shackel, N. A. (2020) · The Medical Journal of Australia · doi:10.5694/mja2.50885 · Cited by 79
Gu, X., Zheng, R., Xia, C., Zeng, H., Zhang, S., Zou, X., Yang, Z., He, L., & Chen, W. (2018) · 癌症:英文版 · doi:10.1186/s40880-018-0308-x · Cited by 78
Schroeder, S., Pedrana, A. E., Scott, N., Wilson, D. P., Kuschel, C., Aufegger, L., Atun, R. A., Baptista‐Leite, R., Butsashvili, M., El-Sayed, M. H., et al. (2019) · Liver International · doi:10.1111/liv.14222 · Cited by 77
Barbosa, J. V., & Lai, M. (2020) · Hepatology Communications · doi:10.1002/hep4.1618 · Cited by 76
Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis
Kew, M. C. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i2.65 · Cited by 71
EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular Carcinoma
Dong, Q., Du, Y., Li, H. Z., Liu, C., Wei, Y., Chen, M., Zhao, X., Chu, Y., Qiu, Y., Qin, L., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1273 · Cited by 71
Tanaka, J., Kurisu, A., Ohara, M., Ouoba, S., Ohisa, M., Sugiyama, A., Wang, M. L., Hiebert, L., Kanto, T., & Akita, T. (2022) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2022.100428 · Cited by 67
Karim, M. A., Singal, A. G., Kum, H., Lee, Y., Park, S., Rich, N. E., Noureddin, M., & Yang, J. D. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.03.010 · Cited by 64
Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
Temraz, S. N., Nassar, F. J., Kreidieh, F., Mukherji, D., Shamseddine, A. I., & Nasr, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157800 · Cited by 62
Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
Kalasekar, S. M., Vansant-Webb, C. H., & Evason, K. J. (2021) · Cancers · doi:10.3390/cancers13215524 · Cited by 62
van Meer, S., de Man, R. A., van den Berg, A. P., Houwen, R. H. J., Linn, F. H. H., van Oijen, M. G. H., Siersema, P. D., & van Erpecum, K. J. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12716 · Cited by 61
Hepatocellular carcinoma in Australia 1982‐2014: Increasing incidence and improving survival
Wallace, M. C., Preen, D. B., Short, M. W., Adams, L. A., & Jeffrey, G. P. (2018) · Liver International · doi:10.1111/liv.13966 · Cited by 60
Mongolia health situation: based on the Global Burden of Disease Study 2019
Chimed‐Ochir, O., Vanya, D., Takahashi, K., Purev, O., Sarankhuu, A., Fujino, Y., Bayarmagnai, N., Dugee, O., Erkhembayar, R., Lkhagvaa, B., et al. (2022) · BMC Public Health · doi:10.1186/s12889-021-12070-3 · Cited by 59
Alcohol Control Policy in Europe: Overview and Exemplary Countries
Berdzuli, N., Ferreira‐Borges, C., Gual, A., & Rehm, J. T. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17218162 · Cited by 54
Iron at the Interface of Hepatocellular Carcinoma
Paganoni, R., Lechel, A., & Spasić, M. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084097 · Cited by 53
African iron overload and hepatocellular carcinoma (HA‐7–0–080)
Moyo, V. M., Makunike-Mutasa, R., Gangaidzo, I. T., Gordeuk, V. R., McLaren, C. E., Khumalo, H., Saungweme, T., Rouault, T. A., & Kiire, C. (1998) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1998.tb00993.x · Cited by 52
Tanaka, Y., Hanada, K., Orito, E., Akahane, Y., Chayama, K., Yoshizawa, H., Sata, M., Ohta, N., Miyakawa, Y., Gojobori, T., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.09.023 · Cited by 51
Baatarkhuu, O., Gerelchimeg, T., Munkh-Orshikh, D., Batsukh, B., Ganbold, S., & Jazag, A. (2018) · Euroasian Journal of Hepato-Gastroenterology · doi:10.5005/jp-journals-10018-1260 · Cited by 51
Tang, S., Zhang, J., Mei, T., Guo, H.-Q., Wei, X., Zhang, W., Liu, Y., Liang, S., Fan, Z.-P., Ma, L., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-6173-4 · Cited by 50
Neto, J. S., Leite, K. R. M., Porta, A., da Fonseca, E. A., Feier, F. H., Pugliese, R. P. S., Miura, I. K., Chapchap, P., & Porta, G. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25094 · Cited by 49
Liver Cancer in Tyrosinemia Type 1
van Ginkel, W. G., Pennings, J. P., & van Spronsen, F. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55780-9_9 · Cited by 48
Hepatocellular carcinoma in children and effect of living‐donor liver transplantation on outcome
Arıkan, Ç., Kilic, M., Nart, D., Özgenç, F., Özkan, T., Tokat, Y., Yagci, R. V., & Aydoğdu, S. (2005) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2005.00395.x · Cited by 44
Hepatocellular carcinoma and African iron overload.
Gangaidzo, I. T., & Gordeuk, V. (1995) · Gut · doi:10.1136/gut.37.5.727 · Cited by 44
Is global elimination of HCV realistic?
Calvaruso, V., Petta, S., & Craxı̀, A. (2018) · Liver International · doi:10.1111/liv.13668 · Cited by 44
Increasing incidence and mortality related to liver cancer in Australia: time to turn the tide
Cocker, F., Yee, K. C., Palmer, A. J., & de Graaff, B. (2019) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.12889 · Cited by 44
de Oliveira, C. P. M. S., Cotrim, H. P., & Arrese, M. (2019) · Clinical Liver Disease · doi:10.1002/cld.759 · Cited by 43
Yang, M., Parikh, N. D., Liu, H., Wu, E., Rao, H., Feng, B., Lin, A., Wei, L., & Lok, A. S.-F. (2020) · Scientific Reports · doi:10.1038/s41598-020-77515-y · Cited by 43
Gabrielson, A. T., Tesfaye, A. A., Marshall, J. L., Pishvaian, M. J., Smaglo, B. G., Jha, R. C., Dorsch‐Vogel, K., Wang, H., & He, A. R. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2852-2 · Cited by 42
Huang, A., Chang, B., Sun, Y., Lin, H., Li, B., Teng, G., & Zou, Z. (2017) · Medicine · doi:10.1097/md.0000000000006163 · Cited by 42
Eguchi, Y., Wong, G., Lee, E. J., Akhtar, O., Lopes, R., & Sumida, Y. (2020) · JGH Open · doi:10.1002/jgh3.12349 · Cited by 40
Farah, M., Anugwom, C. M., Ferrer, J. D., Baca, E. L., de Mattos, Â. Z., Possebon, J. P. P., Arrese, M. A., Prieto, J. E., Balderramo, D. C., Carrera, E., et al. (2022) · Annals of Hepatology · doi:10.1016/j.aohep.2022.100876 · Cited by 40
Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia
Dondog, B., Lise, M., Dondov, O., Baldandorj, B., & Franceschi, S. (2011) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e32833f0c8e · Cited by 39
cellXpress: a fast and user-friendly software platform for profiling cellular phenotypes
Laksameethanasan, D., Tan, R. Z., Toh, G. W.-L., & Loo, L. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-s16-s4 · Cited by 39
Self-citationPNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
Lisboa, Q. C., Nardelli, M. J., Pereira, P. D. A., de Miranda, D. M., Ribeiro, S. N., da Costa, R. S. N., Versiani, C. A., Vidigal, P. V. T., Ferrari, T. C. A., & Couto, C. A. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i10.792 · Cited by 38
Zhang, X., Zhang, X., Liu, M., Zhu, L., & He, Z.-K. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02518-0 · Cited by 38
Mutational Processes in Hepatocellular Carcinoma: The Story of Aristolochic Acid
Nault, J., & Letouzé, É. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1685516 · Cited by 37
Xu, H., Xiao, P., Zhang, F., Liu, T., & Gao, Y. (2022) · Liver International · doi:10.1111/liv.15312 · Cited by 37
Barton, J. C., Acton, R. T., Lee, P. L., & West, C. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.03.008 · Cited by 34
Global Perspective on Hepatitis B Virus Infections in the Era of Effective Vaccines
Gomes, C., Wong, R. J., & Gish, R. G. (2019) · Clinics in Liver Disease · doi:10.1016/j.cld.2019.04.001 · Cited by 34
Epidemiology of non-alcoholic fatty liver disease and risk of hepatocellular carcinoma progression
Thandra, K. C., Barsouk, A. A., Saginala, K., Aluru, J. S., Rawla, P., & Barsouk, A. (2020) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2020.102153 · Cited by 34
Kafeero, H. M., Ndagire, D., Ocama, P., Walusansa, A., & Sendagire, H. (2020) · Virology Journal · doi:10.1186/s12985-020-01443-6 · Cited by 33
Toward improving androgen receptor-targeted therapies in male-dominant hepatocellular carcinoma
Zhang, H., Spencer, K. R., Burley, S. K., & Zheng, X. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.02.001 · Cited by 33
Said, I., Ahad, H., & Said, A. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i5.947 · Cited by 31
Update on Alpha‐1 Antitrypsin Deficiency in Liver Disease
Narayanan, P., & Mistry, P. K. (2020) · Clinical Liver Disease · doi:10.1002/cld.896 · Cited by 27
Prows, C. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1037-9_116 · Cited by 27
Mezina, A. I., Philips, N., Bogus, Z. C., Noam Erez, A., Xiao, R., Fan, R., Olthoff, K. M., Reddy, K. R., Samadder, N. J., Nielsen, S. M., et al. (2021) · JCO Precision Oncology · doi:10.1200/po.21.00079 · Cited by 25
Zibrik, L., Huang, A., WONG, V. C. W., Lauscher, H. N., Choo, Q., Yoshida, E. M., & Ho, K. (2018) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-018-0483-0 · Cited by 22
Álvarez, C. S., Ortiz, J., Bendfeldt‐Avila, G., Xie, Y., Wang, M., Wu, D., Higson, H., Lee, E., Teshome, K., Barnoya, J., et al. (2020) · Health Science Reports · doi:10.1002/hsr2.155 · Cited by 21
Niu, Y., Fan, S., Luo, Q., Chen, L., Huang, D., Chang, W., Qin, W., & Shi, G. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00036 · Cited by 21
Leong, T. K. M., Lo, W. S., Lee, W. E. Z., Tan, B., Lee, X. Z., Lee, L. W. J. N., Lee, J.-Y. J., Suresh, N., Loo, L., Szu, E., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113959 · Cited by 20
Self-citationJunior, P. L. U., Kunze, K. L., Golafshar, M. A., Riegert‐Johnson, D. L., Boardman, L. A., Borad, M. J., Ahn, D., Sonbol, M. B., Faigel, D. O., Fukami, N., et al. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-21-0189 · Cited by 20
Xue, W.-Y., Zhang, L. R., Liu, C., Gao, Y., Li, S., Huai, Z., Dai, J., & Wang, Y. (2022) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2022.2032661 · Cited by 19
The public health challenge of liver cancer in Mongolia
Znaor, A., Chimed, T., Laversanne, M., Tudev, U., Sanjaajamts, E., Sandagdorj, T., & Bray, F. (2018) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(18)30243-7 · Cited by 17
Association between hereditary hemochromatosis and hepatocellular carcinoma: a comprehensive review
Jayachandran, A., Shrestha, R., Bridle, K. R., & Crawford, D. H. (2020) · Hepatoma Research · doi:10.20517/2394-5079.2019.35 · Cited by 17
Zhang, C., Ye, Z., Zhang, Z., Zheng, J., Tang, Y.-M., Hou, E., Huang, Z., & Li, M. (2020) · Gene · doi:10.1016/j.gene.2020.144365 · Cited by 13
Jamialahmadi, O., Bianco, C., Pelusi, S., Romeo, S., & Valenti, L. V. C. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.02.030 · Cited by 13
Wang, H., Gao, P., Chen, W., Yuan, Q., Lv, M., Bai, S., & Wu, J. (2022) · BMC Public Health · doi:10.1186/s12889-022-13175-z · Cited by 12
Cited by
Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
Song, P., Gao, Z., Bao, Y., Chen, L., Huang, Y., Liu, Y., Dong, Q., & Wei, X. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01563-4 · Cited by 382
“Hepatocellular carcinoma HCC is one of the most prevalent carcinomas worldwide and a leading cause of cancer-related death [215].”
BackgroundLiver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 310
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
Chan, Y.-T., Zhang, C., Wu, J., Lu, P., Xu, L., Yuan, H., Feng, Y., Chen, Z.-S., & Wang, N. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02101-z · Cited by 281
Metadata
- Authors
- Toh, M. R., Wong, E. Y. T., Wong, S. H., Ng, A. W. T., Loo, L.-H., Chow, P. K.-H., & Ngeow, J.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2023-04
- Volume
- 164
- Issue
- 5
- Pages
- 766-782
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W4318978952
- Cited by
- 583
- References
- 188
- FWCI
- 82.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.